David Bonita, M.D., is a General Partner of OrbiMed and has been with the company since 2004. Prior to joining OrbiMed, David worked as a corporate finance analyst in the healthcare investment banking groups of Morgan Stanley and UBS. He has also published scientific articles in peer-reviewed journals based on signal transduction research performed at the Harvard Medical School.

David received an A.B. degree in Biological Sciences from Harvard University and a joint M.D./M.B.A. from Columbia University, where he was elected to the Alpha Omega Alpha Medical Honor Society and Beta Gamma Sigma Business Honor Society.